SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-127685
Filing Date
2020-11-20
Accepted
2020-11-20 09:11:28
Documents
13
Period of Report
2020-11-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2036500d1_8k.htm   iXBRL 8-K 24629
2 EXHIBIT 99.1 tm2036500d1_ex99-1.htm EX-99.1 19831
  Complete submission text file 0001104659-20-127685.txt   225609

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ntrp-20201120.xsd EX-101.SCH 3222
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntrp-20201120_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntrp-20201120_pre.xml EX-101.PRE 22734
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2036500d1_8k_htm.xml XML 3631
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38045 | Film No.: 201330628
SIC: 2834 Pharmaceutical Preparations